These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 10706549)

  • 1. p73 is up-regulated in a subset of hepatocellular carcinomas.
    Herath NI; Kew MC; Whitehall VL; Walsh MD; Jass JR; Khanna KK; Young J; Powell LW; Leggett BA; Macdonald GA
    Hepatology; 2000 Mar; 31(3):601-5. PubMed ID: 10706549
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical value of alterations in p73 gene, related to p53 at 1p36, in human hepatocellular carcinoma.
    Aoki T; Miyamoto A; Marubashi S; Nagano H; Umeshita K; Fujiwara Y; Dono K; Nakamori S; Sakon M; Monden M
    Int J Oncol; 2004 Feb; 24(2):441-6. PubMed ID: 14719122
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic alternations of p73 are infrequent but may occur in early stage hepatocellular carcinoma.
    Peng CY; Tsai SL; Yeh CT; Hung SP; Chen MF; Chen TC; Chu CM; Liaw YF
    Anticancer Res; 2000; 20(3A):1487-92. PubMed ID: 10928060
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Frequent loss of heterozygosity at 1p36.3 and p73 abnormality in parathyroid adenomas.
    Shan L; Yang Q; Nakamura Y; Nakamura M; Miyauchi A; Tsujimoto M; Nakatani Y; Wakasa K; Mori I; Kakudo K
    Mod Pathol; 2001 Apr; 14(4):273-8. PubMed ID: 11301342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Absence of mutation of the p73 gene localized at chromosome 1p36.3 in hepatocellular carcinoma.
    Mihara M; Nimura Y; Ichimiya S; Sakiyama S; Kajikawa S; Adachi W; Amano J; Nakagawara A
    Br J Cancer; 1999 Jan; 79(1):164-7. PubMed ID: 10408709
    [TBL] [Abstract][Full Text] [Related]  

  • 6. p73 overexpression and nuclear accumulation in hepatitis C virus-associated hepatocellular carcinoma.
    Zemel R; Koren C; Bachmatove L; Avigad S; Kaganovsky E; Okon E; Ben-Ari Z; Grief F; Ben-Yehoyada M; Shaul Y; Tur-Kaspa R
    Dig Dis Sci; 2002 Apr; 47(4):716-22. PubMed ID: 11991598
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression but lack of mutation and methylation of p73 in hepatocellular carcinoma.
    Pan H; Liao SJ; Lai WY; Lu HC; Hsiao KM
    Acta Oncol; 2002; 41(6):550-5. PubMed ID: 12546528
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Frequent allelic losses on the short arm of chromosome 1 and decreased expression of the p73 gene at 1p36.3 in squamous cell carcinoma of the oral cavity.
    Araki D; Uzawa K; Watanabe T; Shiiba M; Miyakawa A; Yokoe H; Tanzawa H
    Int J Oncol; 2002 Feb; 20(2):355-60. PubMed ID: 11788901
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acquired expression of transcriptionally active p73 in hepatocellular carcinoma cells.
    Sayan AE; Sayan BS; Findikli N; Ozturk M
    Oncogene; 2001 Aug; 20(37):5111-7. PubMed ID: 11526499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative TP73 transcript analysis in hepatocellular carcinomas.
    Stiewe T; Tuve S; Peter M; Tannapfel A; Elmaagacli AH; Pützer BM
    Clin Cancer Res; 2004 Jan; 10(2):626-33. PubMed ID: 14760085
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frequent inactivation of the p73 gene by abnormal methylation or LOH in non-Hodgkin's lymphomas.
    Martinez-Delgado B; Melendez B; Cuadros M; Jose Garcia M; Nomdedeu J; Rivas C; Fernandez-Piqueras J; Benítez J
    Int J Cancer; 2002 Nov; 102(1):15-9. PubMed ID: 12353228
    [TBL] [Abstract][Full Text] [Related]  

  • 12. p73, a gene related to p53, is not mutated in esophageal carcinomas.
    Nimura Y; Mihara M; Ichimiya S; Sakiyama S; Seki N; Ohira M; Nomura N; Fujimori M; Adachi W; Amano J; He M; Ping YM; Nakagawara A
    Int J Cancer; 1998 Nov; 78(4):437-40. PubMed ID: 9797131
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Frequent loss of heterozygosity at 1p36 in ovarian adenocarcinomas but the gene encoding p73 is unlikely to be the target.
    Imyanitov EN; Birrell GW; Filippovich I; Sorokina N; Arnold J; Mould MA; Wright K; Walsh M; Mok SC; Lavin MF; Chenevix-Trench G; Khanna KK
    Oncogene; 1999 Aug; 18(32):4640-2. PubMed ID: 10467409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Family members p53 and p73 act together in chromatin modification and direct repression of alpha-fetoprotein transcription.
    Cui R; Nguyen TT; Taube JH; Stratton SA; Feuerman MH; Barton MC
    J Biol Chem; 2005 Nov; 280(47):39152-60. PubMed ID: 16203738
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of imprinting and elevated expression of wild-type p73 in human gastric adenocarcinoma.
    Kang MJ; Park BJ; Byun DS; Park JI; Kim HJ; Park JH; Chi SG
    Clin Cancer Res; 2000 May; 6(5):1767-71. PubMed ID: 10815895
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of p73 and its relation to histopathology and prognosis in hepatocellular carcinoma.
    Tannapfel A; Wasner M; Krause K; Geissler F; Katalinic A; Hauss J; Mössner J; Engeland K; Wittekind C
    J Natl Cancer Inst; 1999 Jul; 91(13):1154-8. PubMed ID: 10393724
    [TBL] [Abstract][Full Text] [Related]  

  • 17. p73 at chromosome 1p36.3 is lost in advanced stage neuroblastoma but its mutation is infrequent.
    Ichimiya S; Nimura Y; Kageyama H; Takada N; Sunahara M; Shishikura T; Nakamura Y; Sakiyama S; Seki N; Ohira M; Kaneko Y; McKeon F; Caput D; Nakagawara A
    Oncogene; 1999 Jan; 18(4):1061-6. PubMed ID: 10023682
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Down-regulation of p73 correlates with high histological grade in Japanese with breast carcinomas.
    Du CW; Kimijima I; Otake T; Abe R; Takenoshita S; Zhang GJ
    Chin Med J (Engl); 2011 Aug; 124(15):2275-8. PubMed ID: 21933556
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated and biallelic expression of p73 is associated withprogression of human bladder cancer.
    Chi SG; Chang SG; Lee SJ; Lee CH; Kim JI; Park JH
    Cancer Res; 1999 Jun; 59(12):2791-3. PubMed ID: 10383132
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of p53 and its homologues in primary and recurrent squamous cell carcinomas of the head and neck.
    Weber A; Bellmann U; Bootz F; Wittekind C; Tannapfel A
    Int J Cancer; 2002 May; 99(1):22-8. PubMed ID: 11948487
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.